Cancer Cachexia Market Size, Demand, Trends & Analysis 2026-2034
REPORT DETAILS
Cancer Cachexia Market Summary
The cancer cachexia market size was valued at USD 2.58 billion in 2025. The market is anticipated to grow at a CAGR of 4.20% from 2026 to 2034. The rising global incidence of advanced-stage cancers and increasing R&D investments to develop the first targeted, FDA-approved therapies are driving the market growth.
Market Statistics
Key Takeaways
- North America dominated with a 42.6% share in 2025. The rising prevalence of cancer and continuous increase in healthcare budgets contribute to the regional market dominance.
- Asia Pacific is anticipated to grow at a 9.7% CAGR. This is owing to the focus of several governments on establishing well-developed healthcare infrastructure in the region.
- The Progestogens segment accounted for the largest market share of 34.8% in 2025. This dominance is accelerated by the low cost of progestogens as compared to other therapeutics.
- The Combination Therapy segment is projected to grow at a 11.3% CAGR. The segment’s growth is attributed to a rapid increase in the popularity of multimodal treatment among cachexia patients globally.
- The Appetite Stimulators segment held a 38.9% market share in 2025. The segment’s dominance is attributed to their increasing use by cancer patients.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
Cancer cachexia market revenue was valued at USD 2.58 billion in 2025. The market is anticipated to grow from USD 2.69 billion in 2026 to USD 3.73 billion by 2034, exhibiting the CAGR of 4.20% during the forecast period.
Industry Dynamics
- The rapid increase in the prevalence of cancer cachexia across the globe is one of the key factors driving market growth.
- Increased focus of healthcare organizations and private companies on R&D investments and developing new products is shaping the market landscape.
- Emerging therapeutics and pipeline drugs are creating several market opportunities.
- Lack of FDA-approved pharmacological therapies specifically for cachexia may present market challenges.
AI Impact on Cancer Cachexia Market
- AI aids in speeding up research on cancer cachexia by analyzing clinical data, biomarkers, and the health records of patients in order to uncover disease patterns.
- AI assists in diagnosing cancer cachexia and developing a treatment plan according to the prediction of cancer cachexia risks.
- AI makes clinical trials more efficient through effective selection of patients and monitoring of outcomes.
- Continuous patient monitoring is facilitated by AI through predictive analytics and health insights.
Cancer Cachexia Market Definition
The cancer cachexia market comprises treatments, nutritional products, supportive care products, and healthcare services employed to deal with the management of cancer cachexia syndrome, which is an elaborate condition that involves continuous loss of muscle mass, weight loss, and decreased functionality in cancer patients. The market targets improvements in nutritional health, muscle mass retention, quality of life, cancer management, and reduced complications associated with advanced disease stages.
Source: Polaris Market Research Analysis
To Understand More About this Research: Download Sample Report
How Cancer Cachexia Develops?
Cancer-induced Metabolic and Immune Effects: Cancers bring about changes within the body involving the metabolic processes and immune response, causing inflammation and changes in the use of energy.
Inflammatory Process: Inflammation within the body affects the functioning of muscles and adipose tissues through the release of pro-inflammatory mediators, thereby causing continuous degradation of tissues.
Lower Food Consumption: Many patients are affected by appetite suppression, nausea, pain, and difficulties in eating because of the cancer or treatment, which affects food consumption.
Degradation of Muscle and Fat: With the reduction in nutrients and metabolism, the body starts utilizing its fat and muscle stores, which cause sudden weight loss.
Reduction in Physical Activity: Due to degradation of muscles, the patients experience weakness, fatigue, and inability to move around.
Supportive Treatment: Health professionals use nutrition, medicines, exercise, and other techniques to halt the progression of the disease and maintain the muscle mass.
Cancer Cachexia Market Overview and Key Insights
The emergence of cancer cachexia is a serious condition all over the world because it consumes many sources of energy, such as adipose tissue and skeletal muscle. It adversely affects the ability of patients to fight against the infection and also withstand ongoing treatments, including radiotherapy and chemotherapy. Thereby, leading healthcare companies and research institutes are heavily focusing on determining the causes of cachexia and developing solutions to address this health issue.
Furthermore, the management of cancer cachexia has significantly advanced over the years with the emergence of pharmacological perspective & diagnostic-prognostic criteria. Several pharmacological agents, such as non-steroidal anti-inflammatory drugs, appetite stimulants, anabolic agents, & Beta-blockers, have proven efficacy in the treatment of cancer cachexia.
Cancer Cachexia vs Normal Weight Loss
| Factor | Cancer Cachexia | Normal Weight Loss |
| Reason | Cancer-induced metabolic and inflammatory processes | Low intake of calories or lifestyle changes |
| Loss of Muscle | Loss of a lot of muscle tissue | Muscle tissue stays unaltered unless there is malnutrition |
| Loss of Fat | Fat loss happens simultaneously with loss of muscle | Only fat is lost from the body |
| Appetite | Appetite may be decreased because of the disease and treatment | Appetite is usually unaffected or intentionally controlled |
| Reversibility | Unable to reverse using nutrition | Usually is reversible with proper nutrition and lifestyle |
| Effect on Health | Loss of strength, ability to tolerate treatments, and quality of life | Less adverse health outcomes are likely with proper weight loss |
| Approach to Treatment | Nutrition, medications, exercise, and cancer therapy | Balanced nutrition and physical activity |
Source: Polaris Market Research Analysis
Cancer Cachexia Market Drivers and Opportunities
Increasing Prevalence of Cancer Cachexia Cases to Drive Global Market Growth
The rapid increase in the prevalence of cancer cachexia across the globe and the substantial increase in the aging population who are more susceptible to cancer are key factors fostering the market’s growth. Cancer cachexia market drivers include factors such as decreased nutrient absorption, increased fat and protein breakdown, and metabolic dysregulation, among others. For instance, as per a recent report by PubMed Central, around 9 million people worldwide are affected with cancer cachexia, and it is predicted that 20% of cancer deaths are caused by the effect of cachexia among 50-80% of cancer patients.
Rising Investments in R&D Activities Spurring Market Growth
The surging incidence of cancer cachexia among cancer patients globally led to increased focus of healthcare organizations and private companies towards R&D investments and developing new products with enhanced capabilities and characteristics, lead to the cancer cachexia market growth.For instance, in November 2025, Actimed Therapeutics signed an exclusive license deal with Mankind Pharma for the development and marketing of S-pindolol benzoate (ACM-001.1) in India and South Asia territories for the treatment of cancer cachexia. This investment is raised with the purpose of supporting the development of S-pindolol benzoate targeted at cancer cachexia treatment in non-small cell lung cancer.
Role of Nutritional Therapy
Nutrition therapy is an important element in the management of cancer cachexia through enabling adequate calorie and protein consumption despite decreased appetite and persistent weight loss. As cancer cachexia cannot be managed with only nutrition, dietary interventions are often incorporated alongside other types of medical interventions. Nutrition interventions are customized to each patient's health status, cancer stage, and required treatment to keep the body healthy and functioning. Dietary supplements, high-protein diets, and nutritional intervention programs are common approaches to manage nutritional deficiencies. Dietitians coordinate with other team members within the health care team in assessing the patient’s nutrition and making necessary adjustments.
Muscle Wasting and Preservation Strategies
One of the serious effects of cancer cachexia is muscle wasting, which can severely impact the overall well-being of patients. The management of muscle wasting is a complex process that involves several components, including diet, physical exercise, medications, and treatment of the underlying disease. Health professionals advise people to engage in personalized exercises, such as resistance exercises. Proper intake of protein and supplements will also help preserve muscle. Besides, researchers are developing new medications for muscle wasting.
Cancer Cachexia Market Restraints and Challenges
High Treatment Costs and Stringent Regulations Restrict the Market’s Growth
The high cost associated with the treatment of cancer cachexia and the presence of stringent government regulations & reimbursement for therapeutics in developing nations is hampering global market growth. Additionally, treatment of cancer cachexia might also have some side effects that negatively impact their effectiveness and tolerability among patients, which, in turn, hinders the market’s growth.
Source: Polaris Market Research Analysis
Emerging Therapeutic Developments
Cancer cachexia research is paving the way towards developing novel therapeutic approaches targeting the underlying biological mechanisms behind cachexia symptoms such as weight loss and muscle wasting. Research is being carried out on treatment methods addressing inflammatory response, improving appetite, regulating metabolism, and building up muscles. Various novel medications are undergoing clinical trials on their own or combined with nutrition and exercise interventions. Developments in precision medicine are also making it easier for scientists to determine patient response to treatment, thus allowing for tailored therapy. With ongoing research, these novel therapies will become increasingly available.
Impact on Quality of Life
The condition of cancer cachexia can adversely affect the quality of life of a patient through decreased physical strength, energy levels, and performance of activities of daily living. The persistent decrease in body weight and muscle mass can lead to difficulty in performing activities of daily living and increased dependence. Patients may suffer from fatigue, loss of appetite, and decreased tolerance to cancer treatments. Emotional distress in patients as well as their caretakers is possible because of the above-mentioned symptoms of the disease. A holistic approach toward the treatment of the condition, involving nutrition support, symptom control, physical therapy, and psychological support, may be helpful. Timely diagnosis and treatment could help in minimizing the risk of developing complications.
Cancer Cachexia Market Segment Analysis
The market is primarily segmented based on therapeutics, mechanism of action, distribution channel, and region.
| By Therapeutics | By Mechanism of Action | By Distribution Channel | By Region |
|
|
|
|
Source: Polaris Market Research Analysis
Cancer Cachexia Market, by Therapeutics
Progestogens Segment Accounted For the Largest Market Share in 2025
The progestogens segment accounted for the largest cancer cachexia market share in 2025. This dominance is accelerated by the low cost of progestogens as compared to other therapeutics and greater efficiency in the treatment of cancer cachexia. Additionally, progestogens have anti-inflammatory properties that help mitigate the inflammatory processes that contribute to the development of cachexia.
The combination therapy segment will grow at the highest pace. This growth is attributed to a rapid increase in the popularity of multimodal treatment among cachexia patients globally and its ability to address several aspects of cancer cachexia, including inflammation and metabolic alterations.
Cancer Cachexia Market, by Mechanism of Action
Appetite Stimulators Segment Held a Significant Market Size in 2025
The appetite stimulators segment held the majority share in the cancer cachexia market size in 2025. Segment’s dominance is attributed to their increasing use by cancer patients as they frequently develop weight loss as well as loss of appetite. Appetite stimulators are increasingly used to boost food intake and weight gain and help patients maintain a healthy body mass and posture.
In addition, a growing number of research initiatives focused on the creation and development of potential appetite stimulators is expected to raise the market demand for the segment. For instance, in May 2023, researchers at MIT announced the development of a capsule that is able to produce endocrine cells to produce ghrelin, which helps in appetite stimulation.
Cancer Cachexia Market, by Distribution Channel
Online Pharmacy Segment is Expected to Witness the Highest Growth
The online pharmacy segment categorized under the distribution channel is predicted to grow at the highest CAGR during the forecast period. Segment’s cancer cachexia market demand is attributable to the rapid emergence of various online pharmacies as they offer greater convenience to patients to access medication and different medical care products. Also, online pharmacies are gaining traction due to their ability to facilitate the management as well as submission of prescriptions and help patients in the process of obtaining required medications for cancer cachexia.
Use Cases of Cancer Cachexia Management
| Application | Purpose |
| Nutrition Support | Improves intake of calories and proteins |
| Maintaining Muscle Mass | Maintains physical ability and strength |
| Managing Appetite | Improves nutrition and intake of food |
| Nutrition Support During Cancer Treatment | Support for people undergoing chemotherapy, radiation, or surgery treatment |
| Management of Advanced Cancer | Disease management and improving quality of life |
| Palliative Care | For reducing complications and maintaining comfort of a patient |
Source: Polaris Market Research Analysis
Source: Polaris Market Research Analysis
Cancer Cachexia Market Regional Analysis
North America Region Dominated the Global Market in 2025
The North America region dominated the global market. Region’s dominance is attributed to numerous factors such as the rising prevalence of cancer, continuous increase in healthcare budgets, and a number of favorable government initiatives aiming to provide effective treatment options. For instance, according to a report by the American Cancer Society, the number of new cancer deaths in the United States in the year 2022 was approx. 1.9 million and 609,360 respectively.
The Asia Pacific region is anticipated to emerge as the fastest growing region, owing to the increasing population burden and the focus of several governments on establishing well-developed healthcare infrastructure in the region. Also, rapid urbanization and significant lifestyle changes of people in the region have led to a substantial increase in cancer incidences and propelled cancer-associated complications. For instance, according to a report published by the UN, the urban population in India was estimated to be around 675 million in 2035, with a massive increase from 483 million in 2020.
Source: Polaris Market Research Analysis
Cancer Cachexia Market Competitive Landscape
Growing R&D activities and new drug development to drive competition
The cancer cachexia market is moderately competitive in nature due to presence of numerous rivals in the global market. Leading cancer cachexia manufacturers are increasingly investing in research & development activities for the creation of new drugs and formulations and also implementing on different market growth strategies like partnerships, collaborations, acquisitions, and strategic alliances to stay competitive in the market.
Some of the major players operating in the global market include:
- AbbVie Inc. (US)
- Actimed Therapeutics (UK)
- Aeterna Zentaris Inc. (Canada)
- ANI Pharmaceuticals Inc. (US)
- Aphios Corporation (US)
- Aveo Pharmaceuticals Inc. (US)
- Bristol-Myers Squibb Company (US)
- Helsinn Group (Switzerland)
- Hikma Pharmaceuticals PLC (UK)
- Merck & Co. Inc. (US)
- Mylan N.V. (US)
- Pfizer Inc. (US)
- TCI Peptide Therapeutics (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
Future Outlook
The future for the cancer cachexia market seems promising, with increasing awareness about the disease and increasing importance of supportive cancer care in oncology. Research going on in this field is resulting in the creation of new drugs that work against muscle loss, inflammatory responses, and metabolic issues associated with cancer cachexia. Improved nutritional support, personalized therapy, and multidisciplinary care are some of the other ways of managing patients that will be increasingly used in the coming time. Greater emphasis on clinical research and increased knowledge of the disease are helping improve treatment options for the condition. Healthcare providers' emphasis on preserving muscle mass, improving physical function, and enhancing patients' quality of life is expected to lead to greater use of cancer cachexia management practices.
Recent Developments in the Industry
- April 2026: CatalYm announced the first patient being dosed in the Phase 2/3 VINCIT trial (Visugromab IN Cachexia International Trial, NCT07112196). The global study focuses on evaluating CatalYm’s lead anti-GDF-15 antibody visugromab in patients with cancer-associated cachexia.(source: catalym.com)
- In January 2024, Meta Fines announced that they had signed a licensing-out agreement with BMI Korea for their cancer cachexia drug ASCA101_CC. According to this agreement, BMI Korea will hold the rights of global technology transfer of ASCA101_CC along with Meta Fines and will also have the right to license products in a few countries.
Report Coverage
The cancer cachexia market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, cancer cachexia market trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative cancer cachexia market analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The cancer cachexia market report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, therapeutics, mechanism of action, distribution channel, and their futuristic growth opportunities.
Cancer Cachexia Market Report Scope and Methodology
| Report Attributes | Details |
| Market size value in 2025 | USD 2.58 billion |
| Market size value in 2026 | USD 2.69 billion |
| Revenue forecast in 2034 | USD 3.73 billion |
| CAGR | 4.20% from 2026 – 2034 |
| Base year | 2025 |
| Historical data | 2021 – 2024 |
| Forecast period | 2026 – 2034 |
| Quantitative units | Revenue in USD billion and CAGR from 2026 to 2034 |
| Segments covered |
|
| Regional scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, region, and segmentation. |
Source: Polaris Market Research Analysis
Cancer Cachexia Market Frequently Asked Questions
The global cancer cachexia market size is expected to reach USD 3.73 billion by 2034
Key players in the market are Aeterna Zentaris, ANI Pharmaceuticals, Merck & Co. Inc
North America contribute notably towards the global Cancer Cachexia Market
Cancer cachexia market exhibiting the CAGR of 4.20% during the forecast period.
The Cancer Cachexia Market report covering key segments are therapeutics, mechanism of action, distribution channel, and region.
Cancer cachexia is a complex clinical syndrome characterized by unexplained progressive weight loss, muscle wasting, and loss of strength in cancer patients. It cannot be corrected solely with the help of nutrition and may need a combination of medication and supportive care.
Increasing prevalence of cancers, rising awareness about supportive cancer care, advances in research, and improvement of the quality of life of patients are the key drivers of the market growth.
Cancer cachexia is commonly treated with the help of nutrition, medication, physical rehabilitation, exercise, and cancer treatment.
Download Sample Report of Cancer Cachexia Market
Please fill out the form to request a customized copy of the research report.
